Piramal gears up to take Alzheimer's imaging agent to market through IBA deal
This article was originally published in Scrip
Executive Summary
IBA Molecular, a global leader in the nuclear medicine segment, is to manufacture and distribute Piramal Imaging's recently acquired late-stage diagnostic imaging agent, 18F-florbetaben, in Europe and the US.